Paul J. Wang, MD
Academic Appointments
- Professor - Med Center Line, Medicine - Cardiovascular Medicine
- Professor - Med Center Line (By courtesy), Bioengineering
Key Documents
Contact Information
-
Clinical Offices
Cardiovascular Medicine Clinic 300 Pasteur Dr MC 5319 A260 Stanford, CA 94305 Tel Work (650) 723-6459 Fax (650) 723-8392
- Academic Offices
Personal Information Email Tel (650) 723-9363Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cardiac Electrophysiology
- Cardiology (Heart)
- Atrial Fibrillation
- Cardiac Arrhythmias
- Implantable Defibrillators
- Pacemakers
Professional Education
| Fellowship: | Brigham and Women's Hospital, Harvard Medical School, MA USA (1989) |
| Board Certification: | Clinical Cardiac Electrophysiology, American Board of Internal Medicine (1992) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (1986) |
| Medical Education: | College of Physicians & Surgeons, Columbia University NY (1983) |
| Board Certification: | Cardiovascular Disease, American Board of Internal Medicine (1989) |
| Residency: | New York Presbyterian Medical Center NY (1986) |
Graduate & Fellowship Program Affiliations
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information
Scientific Focus
Current Research Interests
Dr. Wang's research centers on the development of innovative approaches to the treatment of arrhythmias, including more effective catheter ablation techniques, more reliable implantable devices, and less invasive treatments. Dr. Wang's clinical research interests include atrial fibrillation, ventricular tachycardia, syncope, and hypertrophic cardiomyopathy. Dr. Wang has active collaborations with Bioengineering, Mechanical Engineering, and Electrical Engineering Departments at Stanford. Some of the goals of his research program are: 1) to create a more effective methods of catheter ablation, 2) to create implantable pacemakers and leads that are more reliable, 3) to create a combined surgical-catheter approach to ablation, 4) to create noninvasive methods of ablation, 5) to make defibrillation painless.
Clinical Trials
- Recruiting Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
- Recruiting Dual Epicardial Endocardial Persistent Atrial Fibrillation (AF) Study ( Staged DEEP)
- Recruiting Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia
- Recruiting Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Publications
- ATP during charging: A failure of therapy? Heart Rhythm. 2013
- Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective Evaluation and Assessment of Therapies in AF (TREAT-AF) study. Am Heart J. 2013; (1): 93-101.e1
- Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation. 2013; (16): 1677-91
- Outcomes from a Postgraduate Biomedical Technology Innovation Training Program: The First 12 Years of Stanford Biodesign. Ann Biomed Eng. 2013
- Ability of microvolt T-wave alternans to modify risk assessment of ventricular tachyarrhythmic events: a meta-analysis. Am Heart J. 2012; (3): 354-64
- Abrupt bradycardia and grouped beating during treadmill testing: a mimic of upper rate behavior. Heart Rhythm. 2012; (7): 1165-7
Help